Navigation Links
GenoLogics Announces Bioinformatics Partnership with Illumina

n their lab with a LIMS and data management system developed specifically to address gene expression and genotyping workflows and genomics applications. This will allow for smooth data flow from one system to another with an integrating LIMS system that acts as the informatics backbone in one or multiple labs.

GenoLogics CEO, Michael Ball adds, "Our partnership with Illumina extends our network of strategic partners, building on one of our core differentiators. Our strong ties with best-in-class vendors enable us to provide end-to-end solutions for applications such as translational medicine and systems biology."

GenoLogics' Geneus provides LIMS functionality specifically for gene expression and genotyping applications and integrates to a wide variety of genomics instruments and software from best-in-class vendors, such as Illumina.

About GenoLogics

GenoLogics is the leading provider of bioinformatics software solutions that help life science laboratories specializing in the field of proteomics, genomics, and systems biology research to manage, integrate, and analyze enormous volumes of scientific and lab data. The Company's mission is to catalyze life sciences research with a collaborative data management software platform, advancing the early detection, prevention, and treatment of disease. For more information, please visit www.genologics.com.

About Illumina

Illumina, Inc. (NASDAQ: ILMN) is a leading developer, manufacturer, and marketer of next-generation life science tools and integrated systems for the large-scale analysis of genetic variation and biological function. Using our proprietary technologies, we provide a comprehensive line of products and services that currently serve the sequencing, genotyping, and gene expression markets, and we expect to enter the market for molecular diagnostics. Our customers include leading genomic research centers, pharmaceutic
'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:5/22/2015)... Fla. , May 22, 2015 ... Heart Institute recently traveled to Boston, ... procedure at the 2015 Heart Rhythm Society conference. ... together to focus on the ideas, people and ... Convergent is a hybrid, minimally invasive cardiac ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
(Date:5/22/2015)... , May 22, 2015 ... Assay Market by Product (Consumables, Instruments, Services), by Test ... (ELISA, Chromatography, Flow Cytometry), by End Users - Global ... Assays Market is expected to reach $736.85 Million by ... CAGR of 10.25%. Browse 71 market ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... Aug. 4 PolyGel® is proud to announce that their ThermoActive ™ Cold & ... , , ... , , ... , This ...
... 4 To combat the escalating global counterfeit drug problem, ... SaaS-based anti-counterfeiting solution.  Both companies expect that, in addition to making ... solution will play a key role in helping them meet upcoming ... , ...
Cached Medicine Technology:PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis 2Two More Global Pharmaceutical Companies Choose New Momentum to Stop Counterfeits 2
(Date:5/24/2015)... Dallas, TX (PRWEB) May 24, 2015 ... the Global and Chinese Enterokinase Industry, 2009-2019 Market Research ... as it is an exhaustive study on the present ... a special insight into the growing Chinese market of ... market and the overall status of the manufacturers in ...
(Date:5/24/2015)... 24, 2015 EnviroLeather™ by LDI, ... Plus” – a classic, rugged leather grain with ... difficult stains, including ink, to be easily removed. ... suitable for corporate, healthcare, hospitality and education environments. ... EnviroLeather’s goal of developing products that are more ...
(Date:5/24/2015)... May 24, 2015 Indiana Fiber Network, ... announces Midwest Telecom of America, Inc. (MTA) has selected ... to Cory Childs, IFN Enterprise Sales Manager, fiber route ... “IFN’s fiber transport provides MTA with the diverse ... their Tier 1 Internet and voice carriers located at ...
(Date:5/24/2015)... A report out just last month ... option for avoiding cardiovascular disease is exercise and maintaining ... single most powerful predictor of death and survival, even ... family history of premature death -- a finding that ... fitness. , The Importance of Cardiovascular Screening , The ...
(Date:5/23/2015)... Dr. David Benvenuti, an experienced plastic surgeon ... new article to his website that takes an ... explained in the fascinating blog, he has recently had ... , Known as “gauging,” the technique involves placing larger and ... said will eventually stretch the holes out to incredible sizes. ...
Breaking Medicine News(10 mins):Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2
... away and lodges in the lung (pulmonary embolism). The aim ... a clearer picture of the increased risk of venous thromboembolism ... doctors in how to prevent the condition arising after a ... out in the University,s Division of Epidemiology and Public Health. ...
... Long-term use of vitamin E and C supplements doesn,t reduce ... finds. "An estimated 20.5 million persons 40 and older ... wrote study author William G. Christen, of Brigham and Women,s ... a news release. Because oxidative damage is a prominent ...
... HealthDay Reporter , THURSDAY, Nov. 11 (HealthDay News) -- ... levels in check as you age is good for your ... suggests the connection between cholesterol and dementia later in life ... women followed for 32 years, Johns Hopkins researchers found that ...
... , WEDNESDAY, Nov. 10 (HealthDay News) -- Hospitals that ... reduced both complications and in-hospital deaths, a new study ... the Netherlands implemented a series of 11 checklists that ... the patient arrived at the hospital until discharge. ...
... 13% of the United States population, are living with ... grow. If current trends continue, there will not be ... To help address this crisis, the American Society of ... Workforce during its upcoming ASN Renal Week 2010 in ...
... scientists at the National Institute of Allergy and ... Health, sheds light on a poorly understood, acute ... develops in some HIV-infected individuals soon after they ... HIV-infected individuals whose immune systems are heavily damaged ...
Cached Medicine News:Health News:Combating cancer's double whammy 2Health News:Study Finds Vitamins E and C Don't Reduce Cataract Risk in Men 2Health News:High Cholesterol in Middle Age May Not Raise Dementia Risk for Women 2Health News:High Cholesterol in Middle Age May Not Raise Dementia Risk for Women 3Health News:Hospital Checklists Reduce Surgical Complications, Deaths: Study 2Health News:Hospital Checklists Reduce Surgical Complications, Deaths: Study 3Health News:ASN leads efforts to address growing crisis in kidney care 2Health News:NIH scientists unveil mechanisms of immune reconstitution inflammatory syndrome 2
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
The SnuggleWarm Convective Warming provides the technology and the tools to effectively enhance the quality of patient care....
The product, which is comprised of a non-intrusive panty-liner, offers a simple to use classification tool that uses color identification for interpretation of the results....
The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Medicine Products: